{"entity":{"type":"insider","cik":"0001339498","url":"/insider/0001339498","json_url":"/insider/0001339498.json","name":"Craig Adam R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":11,"first":"2014-08-29","last":"2026-08-13","span_basis":"filed_date"},"name_variants":[{"name":"Craig Adam R","source":"filing","n_filings":11,"first_seen":"2014-08-29","last_seen":"2026-08-13"}],"transactions":[{"id":9290658,"accession":"0001501697-26-000069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001501697-26-000069","line_url":"/filing/0001501697-26-000069#line-1","is_derivative":false,"issuer_cik":"0001339498","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001339498","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47436.0,"shares_display":"47,436","price_per_share":4.4445,"price_display":"4.44","price_state":"stated","total_value":210829.302,"total_display":"210,829.30","total_whole":"210,829","shares_owned_after":328651.0,"shares_owned_after_display":"328,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-12","filed_date":"2026-08-13","scope":"insider"},{"id":4040766,"accession":"0001501697-25-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001501697-25-000035","line_url":"/filing/0001501697-25-000035#line-1","is_derivative":false,"issuer_cik":"0001339498","issuer_name":"X4 Pharmaceuticals, Inc","issuer_ticker":"XFOR","issuer_name_source":null,"issuer_url":"/issuer/0001339498","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":86206.0,"shares_display":"86,206","price_per_share":2.9,"price_display":"2.90","price_state":"stated","total_value":249997.4,"total_display":"249,997.40","total_whole":"249,997","shares_owned_after":376087.0,"shares_owned_after_display":"376,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-23","filed_date":"2025-10-27","scope":"insider"},{"id":7938818,"accession":"0000891293-23-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000891293-23-000004","line_url":"/filing/0000891293-23-000004","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85317.0,"shares_display":"85,317","price_per_share":6.00024813343179,"price_display":"6.00","price_state":"stated","total_value":511923.17,"total_display":"511,923.17","total_whole":"511,923","shares_owned_after":29440.0,"shares_owned_after_display":"29,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-24","filed_date":"2023-01-26","scope":"insider","n_lines":2},{"id":8309305,"accession":"0000891293-23-000002","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000891293-23-000002","line_url":"/filing/0000891293-23-000002#line-11","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84683.0,"shares_display":"84,683","price_per_share":6.0133,"price_display":"6.01","price_state":"stated","total_value":509224.2839,"total_display":"509,224.28","total_whole":"509,224","shares_owned_after":29440.0,"shares_owned_after_display":"29,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-03","scope":"insider"},{"id":8309301,"accession":"0000891293-23-000002","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000891293-23-000002","line_url":"/filing/0000891293-23-000002","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17100.0,"shares_display":"17,100","price_per_share":6.002777777777778,"price_display":"6.00","price_state":"stated","total_value":102647.5,"total_display":"102,647.50","total_whole":"102,648","shares_owned_after":29440.0,"shares_owned_after_display":"29,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-30","filed_date":"2023-01-03","scope":"insider","n_lines":3},{"id":8309290,"accession":"0000891293-23-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000891293-23-000002","line_url":"/filing/0000891293-23-000002#line-2","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13800.0,"shares_display":"13,800","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":82800.0,"total_display":"82,800.00","total_whole":"82,800","shares_owned_after":27861.0,"shares_owned_after_display":"27,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-29","filed_date":"2023-01-03","scope":"insider"},{"id":6412912,"accession":"0000891293-22-000056","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000891293-22-000056","line_url":"/filing/0000891293-22-000056","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":188304.0,"shares_display":"188,304","price_per_share":6.0046702141218455,"price_display":"6.00","price_state":"stated","total_value":1130703.42,"total_display":"1,130,703.42","total_whole":"1,130,703","shares_owned_after":79757.0,"shares_owned_after_display":"79,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-10","filed_date":"2022-11-14","scope":"insider","n_lines":7},{"id":6412889,"accession":"0000891293-22-000056","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000891293-22-000056","line_url":"/filing/0000891293-22-000056","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53996.0,"shares_display":"53,996","price_per_share":6.001490110378547,"price_display":"6.00","price_state":"stated","total_value":324056.46,"total_display":"324,056.46","total_whole":"324,056","shares_owned_after":35757.0,"shares_owned_after_display":"35,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-09","filed_date":"2022-11-14","scope":"insider","n_lines":3},{"id":6089776,"accession":"0000899243-22-031043","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-031043","line_url":"/filing/0000899243-22-031043#line-2","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":242300.0,"shares_display":"242,300","price_per_share":6.43,"price_display":"6.43","price_state":"stated","total_value":1557989.0,"total_display":"1,557,989.00","total_whole":"1,557,989","shares_owned_after":27861.0,"shares_owned_after_display":"27,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-12","filed_date":"2022-09-14","scope":"insider"},{"id":6116508,"accession":"0000891293-22-000044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000891293-22-000044","line_url":"/filing/0000891293-22-000044#line-1","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":27500.0,"total_display":"27,500.00","total_whole":"27,500","shares_owned_after":27861.0,"shares_owned_after_display":"27,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-16","scope":"insider"},{"id":6644440,"accession":"0000891293-22-000034","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000891293-22-000034","line_url":"/filing/0000891293-22-000034#line-7","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18223.0,"shares_display":"18,223","price_per_share":6.11,"price_display":"6.11","price_state":"stated","total_value":111342.53,"total_display":"111,342.53","total_whole":"111,343","shares_owned_after":22861.0,"shares_owned_after_display":"22,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-06","filed_date":"2022-07-06","scope":"insider"},{"id":6644437,"accession":"0000891293-22-000034","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000891293-22-000034","line_url":"/filing/0000891293-22-000034#line-5","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":162000.0,"total_display":"162,000.00","total_whole":"162,000","shares_owned_after":22861.0,"shares_owned_after_display":"22,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-05","filed_date":"2022-07-06","scope":"insider"},{"id":6644432,"accession":"0000891293-22-000034","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000891293-22-000034","line_url":"/filing/0000891293-22-000034#line-3","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":162000.0,"total_display":"162,000.00","total_whole":"162,000","shares_owned_after":22861.0,"shares_owned_after_display":"22,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-01","filed_date":"2022-07-06","scope":"insider"},{"id":6531668,"accession":"0000891293-22-000027","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000891293-22-000027","line_url":"/filing/0000891293-22-000027#line-6","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18223.0,"shares_display":"18,223","price_per_share":6.01,"price_display":"6.01","price_state":"stated","total_value":109520.23,"total_display":"109,520.23","total_whole":"109,520","shares_owned_after":16678.0,"shares_owned_after_display":"16,678","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-03","scope":"insider"},{"id":6531658,"accession":"0000891293-22-000027","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000891293-22-000027","line_url":"/filing/0000891293-22-000027#line-4","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":162000.0,"total_display":"162,000.00","total_whole":"162,000","shares_owned_after":16678.0,"shares_owned_after_display":"16,678","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-03","scope":"insider"},{"id":6531652,"accession":"0000891293-22-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000891293-22-000027","line_url":"/filing/0000891293-22-000027#line-2","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":162000.0,"total_display":"162,000.00","total_whole":"162,000","shares_owned_after":16678.0,"shares_owned_after_display":"16,678","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-03","scope":"insider"},{"id":5087365,"accession":"0000891293-21-000045","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000891293-21-000045","line_url":"/filing/0000891293-21-000045","is_derivative":false,"issuer_cik":"0000891293","issuer_name":"CTI BIOPHARMA CORP","issuer_ticker":"CTIC","issuer_name_source":null,"issuer_url":"/issuer/0000891293","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":1.5249622285714286,"price_display":"1.52","price_state":"stated","total_value":5337.3678,"total_display":"5,337.37","total_whole":"5,337","shares_owned_after":13500.0,"shares_owned_after_display":"13,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-02","scope":"insider","n_lines":2},{"id":6694376,"accession":"0001179110-14-013437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-013437","line_url":"/filing/0001179110-14-013437#line-1","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":"0001339498","owner_name":"Craig Adam R","owner_display_name":"Craig Adam R","owner_url":"/insider/0001339498","role":"Officer (EVP, Development & CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Development & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Development & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2554.0,"shares_display":"2,554","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":20432.0,"total_display":"20,432.00","total_whole":"20,432","shares_owned_after":12723.0,"shares_owned_after_display":"12,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-27","filed_date":"2014-08-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001501697","name":"X4 Pharmaceuticals, Inc","url":"/issuer/0001501697","role":"Director, Officer (Executive Chairman)","n_filings":2,"first_seen":"2025-10-27","last_seen":"2026-08-13"},{"type":"issuer","type_label":"ISSUER","cik":"0000891293","name":"CTI BIOPHARMA CORP","url":"/issuer/0000891293","role":"Director, Officer (President and CEO)","n_filings":8,"first_seen":"2021-12-02","last_seen":"2023-01-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001061027","name":"SUNESIS PHARMACEUTICALS INC","url":"/issuer/0001061027","role":"Officer (EVP, Development & CMO)","n_filings":1,"first_seen":"2014-08-29","last_seen":"2014-08-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001339498","retrieved_at":"2026-08-26T11:41:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}